-

InTandem Capital Partners Announces Additional Firm Promotions

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners, LLC (“InTandem” or the “Firm”), a healthcare services focused private equity firm, is excited and proud to announce the promotions of two of its team members. These promotions are an important step in InTandem’s evolution and demonstrate the Firm’s commitment to a healthy culture of professional development for its staff.

Greg Martinsen, who joined InTandem in 2020 as Chief Financial Officer, has been promoted to Chief Administrative Officer. Greg will focus on operational and administrative matters for the Firm, including compliance in his continued role of Chief Compliance Officer, and information technology and cyber security infrastructure. Greg has played an integral role over the past five years in helping to institutionalize InTandem’s finance function and will continue to do so on the business side in his new role.

Chris Latino has been promoted to Chief Financial Officer and will oversee InTandem’s finance team with responsibility for all investment vehicle and management company matters. Chris joined InTandem in 2019 as Assistant Controller and this promotion recognizes continued professional growth and deep understanding of InTandem and its finance needs and business processes.

“Greg and Chris have been invaluable team members, and their promotions are recognitions of their success and ability to meet InTandem’s growing needs”, stated Elliot Cooperstone, Managing Partner of InTandem. “We take pride in pursuing and achieving excellence in all that we do, and Greg and Chris’ contributions have been critical in helping us meet that high standard. Congratulations, Greg and Chris.”

We believe that this thoughtfully planned transition will be integral to allow InTandem to scale over the coming years.

About InTandem Capital Partners

InTandem Capital Partners is a private equity firm that invests in and helps accelerate the growth of select healthcare services companies. Its goal is to build excellent businesses of significant value working collaboratively with its management team partners. InTandem is solely focused on investing in businesses that align closely with the Healthcare Quintuple Aim – the simultaneous pursuit of enhanced patient experience, elevated provider experience, improved clinical outcomes, greater healthcare equity, and lower cost of care delivery. The firm is comprised of former business executives and experienced investors, and is uniquely qualified to provide strategic, acquisition and operating expertise to help companies significantly increase their value and their contribution to an improved healthcare system. InTandem provides active support to the management of its portfolio companies directly and leverages its network of industry executives to augment its capabilities. For further information, please visit intandemcapital.com.

Contacts

Media Inquiries:
Janice Rahm
jrahm@intandemcapital.com
612.384.6979

InTandem Capital Partners, LLC


Release Versions

Contacts

Media Inquiries:
Janice Rahm
jrahm@intandemcapital.com
612.384.6979

More News From InTandem Capital Partners, LLC

InTandem Capital Completes Investment in The Phia Group, a Leader in Healthcare Cost Containment

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners, LLC (“InTandem” or the “Firm”), a healthcare services focused private equity firm, announced today that it has completed an equity investment in The Phia Group (the “Company”), an industry leader in healthcare cost containment. Founded in 2000 and headquartered in Canton, Massachusetts, The Phia Group delivers cutting-edge, technology-fueled cost containment and compliance solutions that empower health plan sponsors and employers to provide...

InTandem Capital Partners Announces Senior Advisor Additions

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners, LLC (“InTandem Capital” or the “Firm”), a healthcare services focused private equity firm, is proud to announce the addition of three outstanding healthcare executives to its Senior Advisory team: Brent McCarty, George McMillan and Kevin Quinn. Brent McCarty has over 30 years of experience as a senior executive in the healthcare industry having served as Chief Executive Officer for various private equity backed companies in revenue cycle man...

Adams Clinical Announces Appointment of Dr. Colin Sauder as Chief Scientific Officer and Expansion of Clinical Team to Support Strategic Growth

BOSTON--(BUSINESS WIRE)--Adams Clinical Site Network (“Adams”, or the “Company”), a leading Neuroscience-focused clinical trial site network announced today that Dr. Colin Sauder, PhD has joined the company as Chief Scientific Officer. In his role, Dr. Sauder will oversee clinical and operational teams critical to the company’s strategic growth, including Principal Investigators and Clinical Operations across all Adams Clinical site locations. Dr. Sauder held a pivotal clinical science role at...
Back to Newsroom